Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its fourth quarter that Increases, from last year
The company's earnings came in at $1.191 billion, or $4.65 per share. This compares with $913.0 million, or $3.50 per share, last year.
Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.287 billion or $5.03 per share for the period.
The company's revenue for the period rose 9.5% to $3.190 billion from $2.912 billion last year.
Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: $1.191 Bln. vs. $913.0 Mln. last year.-EPS: $4.65 vs. $3.50 last year.-Revenue: $3.190 Bln vs. $2.912 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.